口服免疫疗法对花生特异性T细胞克隆型的影响。 - Suppr

Changes in peanut-specific T-cell clonotype with oral immunotherapy.

作者信息

Bégin Philippe, Nadeau Kari C

机构信息

Department of Pediatrics, Sainte-Justine Hospital, Montreal, Quebec, Canada; Department of Medicine, University of Montreal Health Center, Montreal, Quebec, Canada.

Division of Allergy, Immunology and Rheumatology, Sean N. Parker Center for Allergy Research at Stanford University, Stanford University School of Medicine, Stanford, Calif.

出版信息

J Allergy Clin Immunol. 2015 Jun;135(6):1636-8. doi: 10.1016/j.jaci.2015.03.010. Epub 2015 Apr 28.

DOI:10.1016/j.jaci.2015.03.010

PMID:25930192

Abstract

摘要

相似文献

Changes in peanut-specific T-cell clonotype with oral immunotherapy.

J Allergy Clin Immunol. 2015 Jun;135(6):1636-8. doi: 10.1016/j.jaci.2015.03.010. Epub 2015 Apr 28.

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.

Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.

Clin Exp Allergy. 2004 Sep;34(9):1422-8. doi: 10.1111/j.1365-2222.2004.02062.x.

Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.

Int Arch Allergy Immunol. 2014;164(3):189-99. doi: 10.1159/000363444. Epub 2014 Jul 15.

Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.

Clin Exp Allergy. 2005 Jun;35(6):757-66. doi: 10.1111/j.1365-2222.2005.02260.x.

Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.

J Allergy Clin Immunol. 2014 Aug;134(2):390-8. doi: 10.1016/j.jaci.2014.03.035. Epub 2014 May 13.

T cell responses to major peanut allergens in children with and without peanut allergy.

Clin Exp Allergy. 2010 Apr;40(4):590-7. doi: 10.1111/j.1365-2222.2009.03431.x. Epub 2010 Jan 11.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):91-6. doi: 10.1016/j.jaip.2013.10.001.

Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression.

J Allergy Clin Immunol. 2006 Oct;118(4):905-14. doi: 10.1016/j.jaci.2006.06.016. Epub 2006 Aug 24.

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

J Allergy Clin Immunol. 2015 Jun;135(6):1546-57.e4. doi: 10.1016/j.jaci.2014.11.028. Epub 2015 Jan 9.

引用本文的文献

Memory Generation and Re-Activation in Food Allergy.

Immunotargets Ther. 2021 Jun 9;10:171-184. doi: 10.2147/ITT.S284823. eCollection 2021.

Cell-by-cell deciphering of T cells in allergic inflammation.

J Allergy Clin Immunol. 2019 Nov;144(5):1143-1148. doi: 10.1016/j.jaci.2019.10.001.

Expansion of the CD4 effector T-cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity.

J Allergy Clin Immunol. 2020 Jan;145(1):270-282. doi: 10.1016/j.jaci.2019.09.033. Epub 2019 Oct 22.

Oral Immunotherapy (OIT): A Personalized Medicine.

Medicina (Kaunas). 2019 Oct 13;55(10):684. doi: 10.3390/medicina55100684.

Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.

Clin Rev Allergy Immunol. 2018 Oct;55(2):172-189. doi: 10.1007/s12016-018-8694-z.

Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut.

J Allergy Clin Immunol. 2018 May;141(5):1699-1710.e7. doi: 10.1016/j.jaci.2018.01.035. Epub 2018 Feb 15.

Oral immunotherapy for food allergy.

Semin Immunol. 2017 Apr;30:36-44. doi: 10.1016/j.smim.2017.08.008. Epub 2017 Aug 31.

Advances in food allergy oral immunotherapy: toward tolerance.

Curr Opin Immunol. 2016 Oct;42:119-123. doi: 10.1016/j.coi.2016.08.002. Epub 2016 Oct 13.

Current and Emerging Therapies for IgE-Mediated Food Allergy.

Curr Allergy Asthma Rep. 2016 Apr;16(4):28. doi: 10.1007/s11882-016-0610-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Changes in peanut-specific T-cell clonotype with oral immunotherapy.

J Allergy Clin Immunol. 2015 Jun;135(6):1636-8. doi: 10.1016/j.jaci.2015.03.010. Epub 2015 Apr 28.

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.

Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.

Clin Exp Allergy. 2004 Sep;34(9):1422-8. doi: 10.1111/j.1365-2222.2004.02062.x.

Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.

Int Arch Allergy Immunol. 2014;164(3):189-99. doi: 10.1159/000363444. Epub 2014 Jul 15.

Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.

Clin Exp Allergy. 2005 Jun;35(6):757-66. doi: 10.1111/j.1365-2222.2005.02260.x.

Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.

J Allergy Clin Immunol. 2014 Aug;134(2):390-8. doi: 10.1016/j.jaci.2014.03.035. Epub 2014 May 13.

T cell responses to major peanut allergens in children with and without peanut allergy.

Clin Exp Allergy. 2010 Apr;40(4):590-7. doi: 10.1111/j.1365-2222.2009.03431.x. Epub 2010 Jan 11.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):91-6. doi: 10.1016/j.jaip.2013.10.001.

Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression.

J Allergy Clin Immunol. 2006 Oct;118(4):905-14. doi: 10.1016/j.jaci.2006.06.016. Epub 2006 Aug 24.

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

J Allergy Clin Immunol. 2015 Jun;135(6):1546-57.e4. doi: 10.1016/j.jaci.2014.11.028. Epub 2015 Jan 9.

引用本文的文献

Memory Generation and Re-Activation in Food Allergy.

Immunotargets Ther. 2021 Jun 9;10:171-184. doi: 10.2147/ITT.S284823. eCollection 2021.

Cell-by-cell deciphering of T cells in allergic inflammation.

J Allergy Clin Immunol. 2019 Nov;144(5):1143-1148. doi: 10.1016/j.jaci.2019.10.001.

Expansion of the CD4 effector T-cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity.

J Allergy Clin Immunol. 2020 Jan;145(1):270-282. doi: 10.1016/j.jaci.2019.09.033. Epub 2019 Oct 22.

Oral Immunotherapy (OIT): A Personalized Medicine.

Medicina (Kaunas). 2019 Oct 13;55(10):684. doi: 10.3390/medicina55100684.

Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.

Clin Rev Allergy Immunol. 2018 Oct;55(2):172-189. doi: 10.1007/s12016-018-8694-z.

Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut.

J Allergy Clin Immunol. 2018 May;141(5):1699-1710.e7. doi: 10.1016/j.jaci.2018.01.035. Epub 2018 Feb 15.

Oral immunotherapy for food allergy.

Semin Immunol. 2017 Apr;30:36-44. doi: 10.1016/j.smim.2017.08.008. Epub 2017 Aug 31.

Advances in food allergy oral immunotherapy: toward tolerance.

Curr Opin Immunol. 2016 Oct;42:119-123. doi: 10.1016/j.coi.2016.08.002. Epub 2016 Oct 13.

Current and Emerging Therapies for IgE-Mediated Food Allergy.

Curr Allergy Asthma Rep. 2016 Apr;16(4):28. doi: 10.1007/s11882-016-0610-0.

Changes in peanut-specific T-cell clonotype with oral immunotherapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献